New ClearPoint Neuro software wins FDA clearance
ClearPoint Neuro (Nasdaq:CLPT) announced that the FDA cleared its ClearPoint 2.2 software with integrated Maestro Brain Modeling.
Source: massdevice.com
Stay updated with breaking news from Maestro Brain Model. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ClearPoint Neuro (Nasdaq:CLPT) announced that the FDA cleared its ClearPoint 2.2 software with integrated Maestro Brain Modeling.
ClearPoint Neuro announces FDA Clearance and first-in-human cases using 2.2 Software with integrated Maestro Brain Modeling, and publication in NeuroImage...
SOLANA BEACH, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platfor...
CLPT earnings call for the period ending March 31, 2022.
CLPT earnings call for the period ending December 31, 2021.